The Use of Libre to Improve Metabolic Control and Reduce Reliance on Medication

Completed · Not applicable

Conditions studied: Diabetes Mellitus, Type 2

In brief

GEM (Glycemic Excursion Minimization) is a new lifestyle treatment for type 2 diabetes that aims to lower glucose levels after meals and snacks. This is different from the current lifestyle treatment, which is to lose weight. This study is trying to find out if people who are newly diagnosed with type 2 diabetes can use a continuous glucose monitor together with the GEM lifestyle to improve control of their diabetes. Study participants will follow the GEM lifestyle for 4 months (1 month of treatment and 3 months of maintenance) instead of seeking usual care (medications or weight loss programs) to lower blood glucose.

Key facts

Study ID
NCT04632849
Run by
University of Virginia
People needed
17
Starts
2020-11-01
Expected to finish
2021-09-01
Last updated by the study team
2021-10-05

Who can join

Age: 35 and older, up to 85. Sex: any. Healthy volunteers: not accepted.

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.